8-K 1 b62077oie8vk.htm OXIGENE, INC. e8vk
 

 
 
United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 14, 2006
 
     
OXiGENE, INC.
(Exact name of registrant as specified in its charter)
 
         
Delaware   0-21990   13-3679168
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)
         
     
230 Third Ave, Waltham, MA 02451
(Address of principal executive offices)
 
Registrant’s telephone number, including area code: (781) 547-5900
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions:
o Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

ITEM 5.02      DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS.
OXiGENE, Inc. (the “Company”) announced that Mr. Scott Young has left his position as the Company’s Chief Operating Officer to pursue other interests, effective August 14, 2006. In connection with his departure from the Company, Mr. Young is entitled to receive a severance payment of two months of his current base salary for each year of his employment with the Company, pursuant to his Employment Agreement with the Company dated January 1, 2002.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
Date: August 18, 2006  OXiGENE, Inc.
 
 
  By:   /s/ James B. Murphy    
    James B. Murphy   
    Vice President and Chief Financial Officer